查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1570831

动物用药品复合市场：依产品、形式、管理、动物、最终用户 - 2025-2030 年全球预测

Animal Drug Compounding Market by Product (Anti-Infective Agents, Anti-Inflammatory Agents, Central Nervous System (CNS) Agents), Form (Capsules, Creams & Gels, Ointments), Administration, Animal, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年动物用药品復配市场价值为11.9亿美元，预计到2024年将达到12.8亿美元，复合年增长率为9.98%，到2030年将达到23.3亿美元。

动物用药品复配是指在市售药物不足的情况下，为满足动物的特定需求和情况而配製定製化药物。这种做法是必要的，因为动物的大小、种类和特定的健康需求各不相同，而标准药物可能无法满足这些需求。例如，较大的动物（例如马）可能需要与较小的动物（例如猫和狗）不同的剂量，并且某些动物可能对某些配方或香料有过敏反应。主要用途包括改变剂量、改变剂型（例如从锭剂到液体）以及添加调味剂以使药物更偏好。最终用途包括兽医院、兽医诊所和牲畜管理设施。市场成长受到全球宠物拥有量的增加、动物慢性疾病的增加以及兽医学中对更个人化医疗的需求的影响。此外，药物配方的进步使得药物组合变得更加精确和有效，从而推动了进一步的需求。目前的商机包括扩展到兽医学不断发展的新兴市场，以及利用科技实现更精确的处方。然而，仍然存在可能阻碍成长的挑战，例如 FDA 等机构的监管障碍以及维持严格的品管标准。确保不同物种药物的安全性和有效性的复杂性使市场扩张更加复杂。创新可以围绕创建更有效率的复合过程、开发更环保、更安全的配方，并利用数位工具实现更准确的剂量。探索替代配方材料和诈欺包装也可能提供竞争优势。与兽医机构的研究和开发合作伙伴伙伴关係可以提供重要的见解并扩大市场基础。最终，我们相信，对个人化动物照护和全球扩大策略的关注对于市场领导者来说至关重要。

主要市场统计
基准年[2023] 11.9亿美元
预测年份 [2024] 12.8亿美元
预测年份 [2030] 23.3亿美元
复合年增长率（%） 9.98%

市场动态：揭示快速发展的动物用药品復配市场的关键市场洞察

供需的动态交互作用正在改变动物用药品復配市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，以及消费行为及其对製造成本的影响及其对采购趋势的影响。

波特五力：驾驭动物用药品復配市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解动物用药品復配市场的外部影响

外部宏观环境因素在塑造动物用药品製剂市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解动物用药品復配市场竞争状况

动物用药品製剂市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵动物用药品復配市场供应商的绩效评估

FPNV定位矩阵是评估动物用药品復配市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划动物用药品復配市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对动物用药品製剂市场进行策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告提供了涵盖主要焦点细分市场的全面市场分析。

1. 市场渗透率：对当前市场环境的详细回顾。

2. 市场开拓：辨识新兴市场的成长机会，评估现有产业的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检视市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球宠物主人数量的数量不断增加，宠物饲主也越来越愿意在宠物身上花钱。
      • 宠物慢性疾病的增加和对特定药物的需求
      • 在世界各地扩大兽医诊所和药房
    • 抑制因素
      • 配方工艺复杂，需熟练人员
    • 机会
      • 动物医药医药理学创新与给药技术进步
      • 与兽医院、宠物保险公司、研究机构建立策略联盟
    • 任务
      • 对动物用药品製剂安全性和有效性的担忧
  • 市场区隔分析
    • 产品：需要发炎药物来应对发炎疾病的流行
    • 最终使用者：在兽医诊所和医院治疗的各种物种和各种医疗状况
  • 波特五力分析
  • PESTLE分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章动物用药品復配市场：副产品

  • 介绍
  • 抗感染剂
  • 发炎剂
  • 中枢神经系统 (CNS) 药物
  • 胃肠医学

第七章动物用药品复方市场：依形式

  • 介绍
  • 胶囊
  • 霜和凝胶
  • 软膏
  • 暂停

第八章动物用药品復配市场：按剂量

  • 介绍
  • 注射
  • 口服
  • 局部的

第九章动物用药品复方市场：依动物分类

  • 介绍
  • 伴同性动物
  • 大型动物
  • 家畜

第十章动物用药品配製市场：依最终用户分类

  • 介绍
  • 牛养殖
  • 宠物饲主
  • 家禽养殖
  • 动物诊所和医院

第十一章：美洲动物用药品復配市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太动物用药品復配市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲动物用药品復配市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Surescripts 和 DAW Systems 之间的策略合作伙伴关係为兽医提供电子处方，提高宠物护理的效率和合规性
    • Mixlab 在 Vanterra Ventures 的支持下收购了 NexGen Animal Health，以扩大大型动物的复合服务
    • Veterinary Pharmaceutical Solutions 透过收购 Diamond Animal Health 巩固市场地位
  • 战略分析和建议
Product Code: MRR-3204321AF708

The Animal Drug Compounding Market was valued at USD 1.19 billion in 2023, expected to reach USD 1.28 billion in 2024, and is projected to grow at a CAGR of 9.98%, to USD 2.33 billion by 2030.

Animal drug compounding refers to the customized preparation of medications for animals, tailored to specific needs and circumstances when commercially available drugs do not suffice. This practice is necessary due to the varied sizes, species, and specific health needs of animals, which standard forms of medication may not fulfill. For instance, large animals like horses may require a different dose compared to smaller animals such as cats or dogs, and some animals may have allergic reactions to certain formulations or flavors. The primary applications include altering drug dosages, changing medication formats (such as from a pill to a liquid), and adding flavors to make medications more palatable. End-use scopes encompass veterinary clinics, animal hospitals, and livestock management facilities. Market growth is influenced by the increasing pet ownership globally, the rise of chronic diseases in animals, and the need for more personalized medicine in veterinary care. Moreover, advancements in pharmaceutical formulations have enabled more precise and effective compounded drugs, driving further demand. Current opportunities include expanding into emerging markets where veterinary health care is growing, and leveraging technology for more accurate formulations. However, challenges persist, including regulatory hurdles imposed by agencies like the FDA and maintaining stringent quality control standards, which can inhibit growth. The complexity of ensuring drug safety and efficacy for varied species further complicates market expansion. Innovations can revolve around creating more efficient compounding processes, developing eco-friendly and safe formulations, and utilizing digital tools for better dosage accuracy. Research into alternative compounding materials and tamper-proof packaging may also offer competitive advantages. Entering collaborative partnerships with veterinary institutions for research and development could provide critical insights and broaden the market reach. Ultimately, a focus on personalized animal care and global expansion strategies could prove pivotal for market leaders.

KEY MARKET STATISTICS
Base Year [2023] USD 1.19 billion
Estimated Year [2024] USD 1.28 billion
Forecast Year [2030] USD 2.33 billion
CAGR (%) 9.98%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Drug Compounding Market

The Animal Drug Compounding Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in pet ownership globally, coupled with the growing willingness of pet owners to spend on their pets
    • Increase in chronic conditions in pets and need for specific medications
    • Expansion of veterinary clinics and pharmacies across the world
  • Market Restraints
    • Complexities in the compounding process and the need for skilled personnel
  • Market Opportunities
    • Innovations in veterinary pharmacology and advancements in drug delivery technologies
    • Establishment of strategic alliances with veterinary clinics, animal hospitals, pet insurance companies, and research institutions
  • Market Challenges
    • Concerns related to the safety and efficacy of animal drug compounding

Porter's Five Forces: A Strategic Tool for Navigating the Animal Drug Compounding Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Drug Compounding Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Drug Compounding Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Drug Compounding Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Drug Compounding Market

A detailed market share analysis in the Animal Drug Compounding Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Drug Compounding Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Drug Compounding Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Drug Compounding Market

A strategic analysis of the Animal Drug Compounding Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Drug Compounding Market, highlighting leading vendors and their innovative profiles. These include Akina Animal Health, Aurora Compounding Pharmacy, Caringbah Compounding Pharmacy, Central Compounding Center South, Chiron Compounding Pharmacy, Inc, Custom-Med Compounding Pharmacy, Davis Islands Pharmacy, Dougherty's Pharmacy, Inc, Hoye's Pharmacy, Medisca Inc., MEDS Canadian Compounding Pharmacy, Millers Pharmacy, Pace Pharmacy, People's Choice of Pharmacy, Pratt's Compounding Pharmacy, Sixth Avenue Medical Pharmacy, Smith Caldwell Drug Store by Walgreen Co., Specialist Compounding Pharmacy Pte Ltd, Tache Pharmacy & Medical Supplies, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy, Victoria Compounding Pharmacy, Vimian Group AB, Wedgewood Pharmacy, and Wellness Pharmacy of Cary.

Market Segmentation & Coverage

This research report categorizes the Animal Drug Compounding Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Anti-Infective Agents, Anti-Inflammatory Agents, Central Nervous System (CNS) Agents, and Gastro-Intestinal(GI) Drugs.
  • Based on Form, market is studied across Capsules, Creams & Gels, Ointments, and Suspension.
  • Based on Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Animal, market is studied across Companion Animals, Large Animals, and Livestock Animals.
  • Based on End-User, market is studied across Cattle Rearing, Pet Owners, Poultry Businesses, and Veterinary Clinics & Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in pet ownership globally, coupled with the growing willingness of pet owners to spend on their pets
      • 5.1.1.2. Increase in chronic conditions in pets and need for specific medications
      • 5.1.1.3. Expansion of veterinary clinics and pharmacies across the world
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in the compounding process and the need for skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations in veterinary pharmacology and advancements in drug delivery technologies
      • 5.1.3.2. Establishment of strategic alliances with veterinary clinics, animal hospitals, pet insurance companies, and research institutions
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to the safety and efficacy of animal drug compounding
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Need for anti-inflammatory agents to cater to the high prevalence of inflammatory conditions
    • 5.2.2. End-User: Extensive range of species and wide variety of medical conditions treated in veterinary clinics and hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Drug Compounding Market, by Product

  • 6.1. Introduction
  • 6.2. Anti-Infective Agents
  • 6.3. Anti-Inflammatory Agents
  • 6.4. Central Nervous System (CNS) Agents
  • 6.5. Gastro-Intestinal(GI) Drugs

7. Animal Drug Compounding Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Creams & Gels
  • 7.4. Ointments
  • 7.5. Suspension

8. Animal Drug Compounding Market, by Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Topical

9. Animal Drug Compounding Market, by Animal

  • 9.1. Introduction
  • 9.2. Companion Animals
  • 9.3. Large Animals
  • 9.4. Livestock Animals

10. Animal Drug Compounding Market, by End-User

  • 10.1. Introduction
  • 10.2. Cattle Rearing
  • 10.3. Pet Owners
  • 10.4. Poultry Businesses
  • 10.5. Veterinary Clinics & Hospitals

11. Americas Animal Drug Compounding Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Animal Drug Compounding Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Animal Drug Compounding Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Strategic Partnership Between Surescripts and DAW Systems Enhances Veterinary e-Prescribing, Boosts Efficiency and Medication Adherence in Pet Care
    • 14.3.2. Mixlab Acquires NexGen Animal Health to Expand Compounding Services to Large Animals with Vanterra Ventures' Backing
    • 14.3.3. Veterinary Pharmaceutical Solutions Strengthens Market Position with Acquisition of Diamond Animal Health
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Akina Animal Health
  • 2. Aurora Compounding Pharmacy
  • 3. Caringbah Compounding Pharmacy
  • 4. Central Compounding Center South
  • 5. Chiron Compounding Pharmacy, Inc
  • 6. Custom-Med Compounding Pharmacy
  • 7. Davis Islands Pharmacy
  • 8. Dougherty's Pharmacy, Inc
  • 9. Hoye's Pharmacy
  • 10. Medisca Inc.
  • 11. MEDS Canadian Compounding Pharmacy
  • 12. Millers Pharmacy
  • 13. Pace Pharmacy
  • 14. People's Choice of Pharmacy
  • 15. Pratt's Compounding Pharmacy
  • 16. Sixth Avenue Medical Pharmacy
  • 17. Smith Caldwell Drug Store by Walgreen Co.
  • 18. Specialist Compounding Pharmacy Pte Ltd
  • 19. Tache Pharmacy & Medical Supplies
  • 20. Triangle Compounding Pharmacy
  • 21. Vertisis Custom Pharmacy
  • 22. Victoria Compounding Pharmacy
  • 23. Vimian Group AB
  • 24. Wedgewood Pharmacy
  • 25. Wellness Pharmacy of Cary

LIST OF FIGURES

  • FIGURE 1. ANIMAL DRUG COMPOUNDING MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL DRUG COMPOUNDING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ANIMAL DRUG COMPOUNDING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. ANIMAL DRUG COMPOUNDING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL DRUG COMPOUNDING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL DRUG COMPOUNDING MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANTI-INFECTIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM (CNS) AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY GASTRO-INTESTINAL(GI) DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CREAMS & GELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY LARGE ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CATTLE REARING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY POULTRY BUSINESSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. ANIMAL DRUG COMPOUNDING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 240. ANIMAL DRUG COMPOUNDING MARKET, FPNV POSITIONING MATRIX, 2023